A preliminary analysis of the balance between Th1 and Th2 cells after CD34 + cell-selected autologous PBSC transplantation

By Endo T   Sato N   Koizumi K   Nishio M   Fujimoto K   Yamamoto S   Sakai T   Bohgaki T   Sawada K   Koike T  

Cytotherapy, Vol. 6, Iss. 4, 2004-08 ,pp. : 337-343

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy

By Chin Sze-Piaw   Poey Alfred C.   Wong Chee-Yin   Chang Sau-Kong   Tan Chiang-Soo   Ng Mei-Theng   Chew Kee-Hock   Lam Kai-Huat   Cheong Soon-Keng  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 814-821

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancer

By Laport G.   Valone F.   Zimmerman T.   Grinblatt D.   van Vlasselaer P.   Still B.   Williams S.  

Cytotherapy, Vol. 2, Iss. 3, 2000-03 ,pp. : 179-185

Ashgate Publishing Ltd

Access to resources Recommend Favorite

GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation

By Zumberg MS   Leather HL   Nejame C   Meyer C   Wingard JR  

Cytotherapy, Vol. 4, Iss. 6, 2002-10 ,pp. : 531-538

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma

By Hiwase DK   Bollard G.   Hiwase S.   Bailey M.   Muirhead J.   Schwarer AP  

Cytotherapy, Vol. 9, Iss. 6, 2007-01 ,pp. : 539-547

Ashgate Publishing Ltd

Access to resources Recommend Favorite